ATE496628T1 - USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS - Google Patents

USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS

Info

Publication number
ATE496628T1
ATE496628T1 AT06743672T AT06743672T ATE496628T1 AT E496628 T1 ATE496628 T1 AT E496628T1 AT 06743672 T AT06743672 T AT 06743672T AT 06743672 T AT06743672 T AT 06743672T AT E496628 T1 ATE496628 T1 AT E496628T1
Authority
AT
Austria
Prior art keywords
lecithin
treat psoriasis
medicine
marine
composition
Prior art date
Application number
AT06743672T
Other languages
German (de)
Inventor
Paul Dupont
Original Assignee
Sc Dicophar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sc Dicophar filed Critical Sc Dicophar
Priority claimed from PCT/FR2006/000792 external-priority patent/WO2006111633A2/en
Application granted granted Critical
Publication of ATE496628T1 publication Critical patent/ATE496628T1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Abstract

Pharmaceutical or cosmetic composition comprising marine lecithin, having a marine phospholipid concentrate, where the composition is useful for preparing a drug to treat psoriasis, is new. ACTIVITY : Dermatological. No biological data given. MECHANISM OF ACTION : None given.
AT06743672T 2005-04-18 2006-04-11 USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS ATE496628T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0503827A FR2884425B3 (en) 2005-04-18 2005-04-18 PHARMACEUTICAL COMPOSITION FOR TREATING PSORIASIS
FR0506496A FR2884423B1 (en) 2005-04-18 2005-06-27 USE OF LECITHIN AS A MEDICINAL PRODUCT IN THE TREATMENT OF PSORIASIS
PCT/FR2006/000792 WO2006111633A2 (en) 2005-04-18 2006-04-11 Use of lecithin as a medicament for treating psoriasis

Publications (1)

Publication Number Publication Date
ATE496628T1 true ATE496628T1 (en) 2011-02-15

Family

ID=35463696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06743672T ATE496628T1 (en) 2005-04-18 2006-04-11 USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS

Country Status (4)

Country Link
AT (1) ATE496628T1 (en)
DE (1) DE602006019842D1 (en)
ES (1) ES2359987T3 (en)
FR (2) FR2884425B3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108004016A (en) * 2017-12-18 2018-05-08 青岛康境海洋生物科技有限公司 A kind of preparation method of the antarctic krill oil of high lecithin content
CN113995763B (en) * 2021-11-10 2023-08-11 中南大学湘雅医院 Application of phosphatidylethanolamine as active ingredient in preparation of psoriasis treatment medicine, psoriasis treatment medicine and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2550397A (en) * 1997-03-25 1998-10-20 Wilson Trafton Crandall Topical moisturizing composition and method
US20020012648A1 (en) * 1998-02-06 2002-01-31 Orthoefer Frank T. High phospholipid-containing dermatological compositions
WO2005002591A1 (en) * 2003-07-02 2005-01-13 Fouad Abdelaziz Ahmed Hassanin Treatment psoriasis, impetigo, tinea by lipositol, cephalin and lecithin

Also Published As

Publication number Publication date
FR2884423A1 (en) 2006-10-20
FR2884423B1 (en) 2007-06-22
ES2359987T3 (en) 2011-05-30
DE602006019842D1 (en) 2011-03-10
FR2884425A1 (en) 2006-10-20
FR2884425B3 (en) 2007-05-25

Similar Documents

Publication Publication Date Title
EA200801717A1 (en) LOCAL APPLICATION COMPOSITION FOR SKIN CARE, PRODUCT ON ITS BASIS AND METHOD OF TREATMENT
EA201300213A1 (en) APPLICATION OF DPP IV INHIBITORS
ATE442142T1 (en) FREDERICAMYCIN DERIVATIVES AS DRUGS FOR TUMOR TREATMENT
PE20050255A1 (en) NEW CYANTIAZOLIDES AND PROCEDURE FOR THEIR PREPARATION AS MEDICINES
EA201290078A1 (en) HETEROCYCLIC COMPOUNDS TO INHIBIT PASK
BRPI0719195B8 (en) kinase inhibitors, their uses, and pharmaceutical composition
ATE410424T1 (en) SPIROCYCLIC CYCLOHEXANE DERIVATIVES
EA200971053A1 (en) METHODS OF TREATMENT OF THE LEAD ULCERS
DE502005008971D1 (en) SUBSTITUTED 1,4,8-TRIAZASPIROÄ4.5 DECAN-2-ON COMPOUNDS FOR THE TREATMENT OF FAT
ATE438623T1 (en) AROYL-O-PIPERIDINE DERIVATIVES FOR THE TREATMENT OF PROBLEMS RELATED TO DIABETES
ATE489935T1 (en) USE OF GLYCYRRHETINIC ACID AND/OR GLYCYRRHIZIN FOR PRODUCING SKIN TANNING PREPARATIONS
EA200601212A1 (en) PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION
BRPI0410979A (en) compound, pharmaceutical composition, and methods for treating a cathepsin-mediated disease in an animal and for treating a patient undergoing therapy
EA200601288A1 (en) 1,3-DIPHENYLPROP-2-EN-1-SHE DERIVATIVES, METHOD OF THEIR RECEIVING AND APPLICATION
EA200801580A1 (en) NEW PIRININOD DERIVATIVES AND METHOD FOR THEIR PRODUCTION
ATE495728T1 (en) COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING N-ACETYLCYSTONE
ATE510536T1 (en) USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF REACTIVE TISSUE DISEASES
BRPI0507321A (en) cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, processes for producing them and using them as a medicine
Han et al. Anti-photoaging effect of hydrolysates from pacific whiting skin via MAPK/AP-1, NF-κB, TGF-β/Smad, and Nrf-2/HO-1 signaling pathway in UVB-induced human dermal fibroblasts
EA200900269A1 (en) DRUG COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
ATE553760T1 (en) USE OF ALVERINE TO TREAT SKIN DISEASES
WO2007025229A3 (en) Compositions and their uses directed to hsp27
NO20075199L (en) Treatment or prevention of pruritus
ATE496628T1 (en) USE OF LECITHIN AS A MEDICINE TO TREAT PSORIASIS
ATE391710T1 (en) SUBSTITUTED AZETIDINE COMPOUNDS AS CYCLOOXIGENASE-1-CYCLOOXYGENASE-2 INHIBITORS AND THEIR PREPARATION AND USE AS A MEDICATION

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties